American Journal of Kidney Diseases
Volume 53, Issue 4 , Pages 596-605 , April 2009

Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) Study

  • Lori D. Bash, MPH

      Affiliations

    • Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD
    • Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University, Baltimore, MD
    • Corresponding Author InformationAddress correspondence to Lori D. Bash, MPH, Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins Bloomberg School of Public Health, 2024 E Monument St, Ste 2-604, Baltimore, MD 21201
    • ,
  • Thomas P. Erlinger, MD, MPH

      Affiliations

    • Seton Hospital, Austin, TX
    • ,
  • Josef Coresh, MD, PhD

      Affiliations

    • Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD
    • Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University, Baltimore, MD
    • Department of Medicine, Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • Department of Biostatistics, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • ,
  • Jane Marsh-Manzi, PhD

      Affiliations

    • Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University, Baltimore, MD
    • ,
  • Aaron R. Folsom, MD, MPH

      Affiliations

    • Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN
    • ,
  • Brad C. Astor, PhD, MPH

      Affiliations

    • Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD
    • Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University, Baltimore, MD
    • Department of Medicine, Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

Received 21 July 2008 ,Accepted 10 October 2008.

References 

  1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health And Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  2. Collins AJ, Kasiske B, Herzog C, et al. US Renal Data System Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2005;45:A5–A7
  3. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14:2934–2941
  4. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13–18
  5. Erlinger TP, Tarver-Carr ME, Powe NR, et al. Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis. 2003;42:256–263
  6. Fried L, Solomon C, Shlipak M, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004;15:3184–3191
  7. Kshirsagar AV, Bomback AS, Bang H, et al. Association of C-reactive protein and microalbuminuria (from the National Health And Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol. 2008;101:401–406
  8. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int. 2000;57:2072–2079
  9. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? (Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study). Kidney Int. 2002;62:963–970
  10. Sarnak MJ, Poindexter A, Wang SR, et al. Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int. 2002;62:2208–2215
  11. ARIC Investigators. The Atherosclerosis Risk In Communities (ARIC) Study: Design and objectives. Am J Epidemiol. 1989;129:687–702
  12. Shoham DA, Vupputuri S, Diez Roux AV, et al. Kidney disease in life-course socioeconomic context: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2007;49:217–226
  13. National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study: Operations manual no. 10: clinical chemistry determinations. Version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987;
  14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  15. Eckfeldt JH, Chambless LE, Shen YL. Short-term, within-person variability in clinical chemistry test results (Experience from the Atherosclerosis Risk In Communities study). Arch Pathol Lab Med. 1994;118:496–500
  16. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study—I (Development of a blood collection and processing system suitable for multicenter hemostatic studies). Thromb Haemost. 1989;61:15–19
  17. National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study: Operation manual no. 9: hemostasis determinations. Version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987;
  18. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke (The Atherosclerosis Risk in Communities (ARIC) Study Investigators). Circulation. 1999;100:736–742
  19. Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen YL. Short-term intraindividual variability in hemostasis factors (The ARIC Study. Atherosclerosis Risk in Communities intraindividual variability study). Ann Epidemiol. 1992;2:723–733
  20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  21. Carroll R, Stefanski L. Approximate quasilikelihood estimation in models with surrogate predictors. J Am Stat Assoc. 1990;85:652–663
  22. Gleser LJ. Improvements of the naïve approach to estimation in nonlinear errors-in-variables regression models. In:  Brown PJ,  Fuller WA editor. Statistical Analysis of Measurement Error Models and Applications. Providence, RI: American Mathematical Society; 1990;p. 99–114
  23. Hardin J, Schmiediche H, Carroll R. The regression calibration method for fitting generalized linear models with additive measurement error. Stata J. 2003;3:361–372
  24. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA. 1998;279:1477–1482
  25. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: The Heart and Soul Study. Nephrol Dial Transplant. 2007;22:1087–1092
  26. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JE. Diabetes and advanced glycoxidation end products. Diabetes Care. 2006;29:1420–1432
  27. Cooper ME. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. Am J Hypertens. 2004;17(12 pt 2):31S–38S
  28. Forbes JM, Thallas-Bonke V, Cooper ME, Thomas MC. Advanced glycation: How are we progressing to combat this web of sugar anomalies in diabetic nephropathy. Curr Pharm Des. 2004;10:3361–3372
  29. Forbes JM, Fukami K, Cooper ME. Diabetic nephropathy: Where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes. 2007;115:69–84
  30. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation. 2007;116:1234–1241
  31. Sika M, Lewis J, Douglas J, et al. AASK Group Baseline characteristics of participants in the African American Study of Kidney disease and Hypertension (AASK) clinical trial and cohort study. Am J Kidney Dis. 2007;50:78–8989.e1
  32. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 1992;340:319–323
  33. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian cardiac outcomes trial (ASCOT). J Am Coll Cardiol. 2004;44:415–422
  34. Catena C, Zingaro L, Casaccio D, Sechi LA. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med. 2000;109:556–561

 Originally published online as doi:10.1053/j.ajkd.2008.10.044 on December 25, 2008.

 Because the Editor-in-Chief recused himself from consideration of this manuscript, the Deputy Editor (Daniel E. Weiner, MD, MS) served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(08)01620-X

doi: 10.1053/j.ajkd.2008.10.044

American Journal of Kidney Diseases
Volume 53, Issue 4 , Pages 596-605 , April 2009

Article Tools

* Image Usage & Resolution